| Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 developed countries JE Bekelman, SD Halpern, CR Blankart, JP Bynum, J Cohen, R Fowler, ... Jama 315 (3), 272-283, 2016 | 479 | 2016 |
| Availability of and access to orphan drugs: an international comparison of pharmaceutical treatments for pulmonary arterial hypertension, Fabry disease, hereditary angioedema … CR Blankart, T Stargardt, J Schreyögg Pharmacoeconomics 29, 63-82, 2011 | 103 | 2011 |
| International Consortium for End-of-Life Research (ICELR). Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 … JE Bekelman, SD Halpern, CR Blankart, JP Bynum, J Cohen, R Fowler, ... Jama 315 (3), 272-283, 2016 | 76 | 2016 |
| Health technology assessment of medical devices: a survey of non-European union agencies O Ciani, B Wilcher, CR Blankart, M Hatz, VP Rupel, RS Erker, ... International journal of technology assessment in health care 31 (3), 154-165, 2015 | 74 | 2015 |
| The determinants of medical technology adoption in different decisional systems: A systematic literature review Y Varabyova, CR Blankart, AL Greer, J Schreyögg Health Policy 121 (3), 230-242, 2017 | 58 | 2017 |
| Does healthcare infrastructure have an impact on delay in diagnosis and survival? CR Blankart Health Policy 105 (2-3), 128-137, 2012 | 57 | 2012 |
| Cost of illness and economic burden of chronic lymphocytic leukemia CR Blankart, T Koch, R Linder, F Verheyen, J Schreyögg, T Stargardt Orphanet journal of rare diseases 8, 1-9, 2013 | 53 | 2013 |
| The health care strengthening act: the next level of integrated care in Germany R Milstein, CR Blankart Health Policy 120 (5), 445-451, 2016 | 47 | 2016 |
| Economic burden and quality-of-life effects of chronic lymphocytic leukemia: a systematic review of the literature S Frey, CR Blankart, T Stargardt Pharmacoeconomics 34, 479-498, 2016 | 36 | 2016 |
| Adoption decisions for medical devices in the field of cardiology: results from a European survey MHM Hatz, J Schreyögg, A Torbica, G Boriani, CRB Blankart Health economics 26, 124-144, 2017 | 29 | 2017 |
| Differences in health care spending and utilization among older frail adults in high‐income countries: ICCONIC hip fracture persona I Papanicolas, JF Figueroa, AJ Schoenfeld, K Riley, O Abiona, M Arvin, ... Health services research 56, 1335-1346, 2021 | 28 | 2021 |
| Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal B Pongiglione, A Torbica, H Blommestein, S de Groot, O Ciani, S Walker, ... International journal of technology assessment in health care 37 (1), e62, 2021 | 28 | 2021 |
| The economic impact of Marfan syndrome: a non-experimental, retrospective, population-based matched cohort study D Achelrod, CR Blankart, R Linder, YK Von Kodolitsch, T Stargardt Orphanet journal of rare diseases 9, 1-12, 2014 | 28 | 2014 |
| International comparison of health spending and utilization among people with complex multimorbidity JF Figueroa, I Papanicolas, K Riley, O Abiona, M Arvin, F Atsma, ... Health Services Research 56, 1317-1334, 2021 | 26 | 2021 |
| Comparing the efficiency of hospitals in Italy and Germany: Nonparametric conditional approach based on partial frontier Y Varabyova, CR Blankart, A Torbica, J Schreyögg Health Care Management Science 20, 379-394, 2017 | 26 | 2017 |
| The PMA scale: a measure of physicians’ motivation to adopt medical devices MHM Hatz, T Sonnenschein, CR Blankart Value in health 20 (4), 533-541, 2017 | 26 | 2017 |
| The role of learning in health technology assessments: an empirical assessment of endovascular aneurysm repairs in German Hospitals Y Varabyova, CR Blankart, J Schreyögg Health economics 26, 93-108, 2017 | 23 | 2017 |
| Improving health care from the bottom up: Factors for the successful implementation of kaizen in acute care hospitals K Shatrov, C Pessina, K Huber, B Thomet, A Gutzeit, CR Blankart PloS one 16 (9), e0257412, 2021 | 21 | 2021 |
| Using nonparametric conditional approach to integrate quality into efficiency analysis: empirical evidence from cardiology departments Y Varabyova, CR Blankart, J Schreyögg Health Care Management Science 20, 565-576, 2017 | 21 | 2017 |
| Regulatory and HTA early dialogues in medical devices CR Blankart, F Dams, H Penton, Z Kaló, A Zemplényi, K Shatrov, ... Health Policy 125 (10), 1322-1329, 2021 | 15 | 2021 |
Jonas SchreyöggProfessor für Management im Gesundheitswesen, Universität HamburgVerified email at uni-hamburg.de
